In a major move to bring AI to the bedside, healthtech startup HealthLeap announced today that it is deploying its AI-driven clinical screening platform across the entire Houston Methodist health system.
The enterprise-wide rollout will automatically screen all of Houston Methodist’s 150,000-plus annual inpatients for clinical risks, starting with a massive, often-overlooked hospital liability: malnutrition.
For the broader healthcare industry, this partnership represents a critical shift in how hospital executives are evaluating and deploying artificial intelligence. Rather than adopting flashy generative AI for back-office administrative tasks, Houston Methodist is embedding a validated, machine-learning-driven safety net directly into its active clinical workflows to intervene in patient care earlier.
The Scope of the Rollout
Until now, identifying patients at risk of severe nutritional deficit has been a notoriously analog process. Nationwide, hospitals rely heavily on admission-day questionnaires filled out by nursing staff. Because these screenings are static, they often fail to capture patients whose conditions deteriorate days into their stay. As a result, while up to 50% of hospitalized patients are at risk for malnutrition, fewer than 9% are formally identified.
Under the new deployment, HealthLeap’s AI will operate continuously in the background of Houston Methodist’s Electronic Health Record (EHR) system from a patient’s admission through their discharge.
- Continuous Monitoring: The platform ingests and analyzes a patient’s entire chart in real time, pulling from clinical notes, lab results, vitals, active medication orders, and problem lists.
- Workflow Integration: Rather than requiring clinicians to open a separate application, actionable risk scores and priority alerts are pushed directly into the native EHR interfaces used by care teams.
- Validated Accuracy: According to the company, HealthLeap’s platform is 88% more accurate at identifying clinical risk than existing manual screening methods.
“At Houston Methodist, we are focused on strengthening how we identify patients who may benefit from additional nutrition support,” said Michelle Stansbury, Associate Chief Innovation Officer and VP of IT Applications at Houston Methodist. “By incorporating advanced screening tools into the clinical workflow, we can help care teams recognize risk earlier, intervene sooner, and support more timely recovery for patients.”
For Houston Methodist, the decision to implement HealthLeap systemwide goes beyond basic clinical quality, it is deeply tied to hospital operations and financial sustainability. When malnutrition is missed, it triggers a costly cascade of clinical consequences, including slower healing, higher rates of infection, and extended hospital stays.
“It’s an honor to support Houston Methodist in advancing an approach that strengthens early identification and proactive patient care,” said Josiah Meyer, Chief Executive Officer and Co-founder of HealthLeap.
What This Means For Healthcare AI
The Houston Methodist partnership serves as a major commercial validation for HealthLeap, which claims to be the only commercially available, peer-reviewed AI platform in the malnutrition screening category.
By proving it can operate effectively “upstream” of traditional clinical decision support, identifying at-risk patients before downstream processes fail, HealthLeap is carving out a lucrative niche. As hospital systems face compounding margin pressures and staffing shortages, the startups that succeed will be the ones that, like HealthLeap, manage to turn invisible clinical risks into measurable financial and operational wins.
Companies can learn more at https://www.healthleap.ai/.
